Cresset Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Sell |
3,015
-1,128
| -27% | -$592K | 0.01% | 622 |
|
|
2025
Q1 | $2.63M | Sell |
4,143
-128
| -3% | -$81.2K | 0.01% | 457 |
|
|
2024
Q4 | $3.04M | Sell |
4,271
-6,164
| -59% | -$4.39M | 0.01% | 433 |
|
|
2024
Q3 | $11M | Buy |
10,435
+198
| +2% | +$208K | 0.04% | 278 |
|
|
2024
Q2 | $10.8M | Buy |
10,237
+740
| +8% | +$778K | 0.05% | 256 |
|
|
2024
Q1 | $9.14M | Buy |
9,497
+26
| +0.3% | +$25K | 0.04% | 267 |
|
|
2023
Q4 | $8.32M | Buy |
9,471
+607
| +7% | +$533K | 0.05% | 240 |
|
|
2023
Q3 | $7.29M | Buy |
8,864
+43
| +0.5% | +$35.4K | 0.03% | 238 |
|
|
2023
Q2 | $6.34M | Buy |
8,821
+6,874
| +353% | +$4.94M | 0.01% | 264 |
|
|
2023
Q1 | $1.6M | Buy |
1,947
+73
| +4% | +$60K | 0.03% | 260 |
|
|
2022
Q4 | $1.27M | Sell |
1,874
-133
| -7% | -$90.1K | 0.02% | 267 |
|
|
2022
Q3 | $1.38M | Sell |
2,007
-29
| -1% | -$20K | 0.02% | 280 |
|
|
2022
Q2 | $1.18M | Buy |
2,036
+597
| +41% | +$346K | 0.01% | 342 |
|
|
2022
Q1 | $1.01M | Sell |
1,439
-203
| -12% | -$142K | 0.01% | 405 |
|
|
2021
Q4 | $1.04M | Buy |
1,642
+208
| +15% | +$131K | 0.01% | 445 |
|
|
2021
Q3 | $868K | Buy |
1,434
+90
| +7% | +$54.5K | 0.01% | 438 |
|
|
2021
Q2 | $751K | Sell |
1,344
-651
| -33% | -$364K | 0.01% | 432 |
|
|
2021
Q1 | $943K | Buy |
1,995
+744
| +59% | +$352K | 0.01% | 321 |
|
|
2020
Q4 | $604K | Sell |
1,251
-149
| -11% | -$71.9K | 0.01% | 349 |
|
|
2020
Q3 | $784K | Buy |
1,400
+49
| +4% | +$27.4K | 0.01% | 266 |
|
|
2020
Q2 | $843K | Buy |
1,351
+392
| +41% | +$245K | 0.02% | 238 |
|
|
2020
Q1 | $370K | Buy |
959
+400
| +72% | +$154K | 0.01% | 342 |
|
|
2019
Q4 | $210K | Buy |
+559
| New | +$210K | 0.01% | 547 |
|
|
2019
Q2 | – | Sell |
-495
| Closed | -$203K | – | 1405 |
|
|
2019
Q1 | $203K | Buy |
495
+72
| +17% | +$29.5K | 0.01% | 372 |
|
|
2018
Q4 | $158K | Buy |
+423
| New | +$158K | 0.01% | 253 |
|